391 related articles for article (PubMed ID: 29687537)
21. The frequency and malignancy rate of incidental focal breast lesions identified by 18F-fluorodeoxyglucose positron emission tomography.
Andersen JD; Zacho HD; Petersen LJ
Nucl Med Commun; 2021 Jan; 42(1):93-100. PubMed ID: 33044407
[TBL] [Abstract][Full Text] [Related]
22. Significance of incidentally detected subcentimeter enhancing lesions on preoperative breast MRI: role of second-look ultrasound in lesion detection and management.
Nam SJ; Kim EK; Kim MJ; Moon HJ; Yoon JH
AJR Am J Roentgenol; 2015 Mar; 204(3):W357-62. PubMed ID: 25714322
[TBL] [Abstract][Full Text] [Related]
23. Incidental breast lesions detected on CT: what is their significance?
Moyle P; Sonoda L; Britton P; Sinnatamby R
Br J Radiol; 2010 Mar; 83(987):233-40. PubMed ID: 19546179
[TBL] [Abstract][Full Text] [Related]
24. Using the 3-tiered system for categorizing workup of incidental thyroid nodules detected on CT, MRI, or PET/CT: how many cancers would be missed?
Bahl M; Sosa JA; Eastwood JD; Hobbs HA; Nelson RC; Hoang JK
Thyroid; 2014 Dec; 24(12):1772-8. PubMed ID: 25203387
[TBL] [Abstract][Full Text] [Related]
25. The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study.
Siewert B; Millo NZ; Sahi K; Sheiman RG; Brook OR; Sun MRM; Kane RA
Radiology; 2018 Apr; 287(1):156-166. PubMed ID: 29369753
[TBL] [Abstract][Full Text] [Related]
26. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
[TBL] [Abstract][Full Text] [Related]
27. Elastofibroma dorsi incidentally detected by (18)F-FDG PET/CT imaging.
Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF; Findikcioglu A; Canpolat T
Ann Nucl Med; 2015 Jun; 29(5):420-5. PubMed ID: 25666569
[TBL] [Abstract][Full Text] [Related]
28. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
Adas M; Adas G; Koc B; Ozulker F
Minerva Endocrinol; 2015 Sep; 40(3):169-75. PubMed ID: 26205646
[TBL] [Abstract][Full Text] [Related]
29. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T.
Magometschnigg HF; Baltzer PA; Fueger B; Helbich TH; Karanikas G; Dubsky P; Rudas M; Weber M; Pinker K
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1656-1665. PubMed ID: 26121928
[TBL] [Abstract][Full Text] [Related]
31. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions.
Gutierrez RL; Demartini WB; Eby P; Kurland BF; Peacock S; Lehman CD
Acad Radiol; 2009 Oct; 16(10):1281-5. PubMed ID: 19733804
[TBL] [Abstract][Full Text] [Related]
32. Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
Yerubandi V; Chin BB; Sosa JA; Hoang JK
AJR Am J Roentgenol; 2016 Feb; 206(2):420-5. PubMed ID: 26797373
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
34. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
35. Community-based practice experience of unsuspected breast magnetic resonance imaging abnormalities evaluated with second-look sonography.
Destounis S; Arieno A; Somerville PA; Seifert PJ; Murphy P; Morgan R; Skolny M; Hanson S; Young W
J Ultrasound Med; 2009 Oct; 28(10):1337-46. PubMed ID: 19778880
[TBL] [Abstract][Full Text] [Related]
36. Magnetic Resonance Imaging-Directed Ultrasound Imaging of Non-Mass Enhancement in the Breast: Outcomes and Frequency of Malignancy.
Newburg AR; Chhor CM; Young Lin LL; Heller SL; Gillman J; Toth HK; Moy L
J Ultrasound Med; 2017 Mar; 36(3):493-504. PubMed ID: 28108994
[TBL] [Abstract][Full Text] [Related]
37. Detection of unexpected additional primary malignancies with PET/CT.
Ishimori T; Patel PV; Wahl RL
J Nucl Med; 2005 May; 46(5):752-7. PubMed ID: 15872346
[TBL] [Abstract][Full Text] [Related]
38. Suspicious breast lesions incidentally detected on chest computer tomography with histopathological correlation.
Georgieva M; Rennert J; Brochhausen C; Stroszczynski C; Jung EM
Breast J; 2021 Sep; 27(9):715-722. PubMed ID: 34124813
[TBL] [Abstract][Full Text] [Related]
39. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
40. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Brindle R; Mullan D; Yap BK; Gandhi A
Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
